NORTHVALE, N.J.--(BUSINESS WIRE)--Elite Pharmaceutical, Inc.’s (AMEX: ELI) marketing partner, ECR Pharmaceuticals, has launched Elite’s second once-a-day allergy product, under ECR’s brand LODRANE 24D, an extended release formulation of brompheniramine maleate and pseudoephedrine HCl.
